Skip to main content
Top
Published in: Critical Care 1/2020

01-12-2020 | Acute Kidney Injury | Letter

Biomarkers to delineate bacteremia from candidemia remain a challenging issue

Authors: Patrick M. Honore, Christina David, Rachid Attou, Sebastien Redant, Andrea Gallerani, David De Bels

Published in: Critical Care | Issue 1/2020

Login to get access

Excerpt

In their recent systematic review, Cortegiani et al. found that serum procalcitonin (PCT) concentrations were higher in patients with bacteremia as compared to candidemia [1]. Quality of data was poor and did not allow to use PCT alone to differentiate bacteremia from candidemia [1]. While we agree with their findings regarding patients with positive hemocultures in the ward, we would like to address the results of the patients with positive hemocultures in the intensive care unit (ICU) [1]. In a randomized controlled study (RCT) comparing the clinical manifestations of septic shock caused by bacteria or Candida spp., the rate of acute kidney injury (AKI) defined by a creatinine above 3.5 mg/dl or the need of any form of renal replacement therapy (RRT) was around 20% in the bacteria group versus above 40% in the candida group, while having similar Acute Physiology and Chronic Health Evaluation (APACHE) II scores [2]. Accordingly, the rate of RRT in the candidemia group will be twice as high as compared to the bacteremia group [2]. It is plausible that there are similar trends in the Cortegiani study [2]. PCT has an approximate molecular weight of 14.5 kDa [3]. The contemporary continuous RRT (CRRT) membranes are able to remove molecules as large as 35 kDa [3]. Hence, most of the PCT mass will be eliminated by convective flow [3], but adsorption also contributes to elimination if using new highly adsorptive membranes (HAM) [4]. Accordingly, imbalance between the use of CRRT in the two cohorts (bacteremia versus candidemia) will have an important impact upon the values of PCT in each cohort. PCT levels may therefore be affected not only by the type of pathogen but also by the incidence of RRT. A future study with a focus on the performance of the currently known sepsis biomarkers among those who receive CRRT is urgently needed [4]. As alluded too by Cortegiani et al., beta-d-glucan (BDG) could be a very good candidate associated to PCT. Indeed, BDG could be even a better candidate as its molecular weight ranges from several hundred thousand to 10 million daltons and does not pass through any membrane [4, 5]. Finally, we would like to add that BDG can be also be falsely elevated in case of gastrointestinal colonization of Candida albicans that increases serum BDG without candidemia [5]. …
Literature
3.
go back to reference Level C, Chauveau P, Guisset O, Cazin MC, Lasseur C, Gabinsky C, et al. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care. 2003;6:R160–6.CrossRef Level C, Chauveau P, Guisset O, Cazin MC, Lasseur C, Gabinsky C, et al. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care. 2003;6:R160–6.CrossRef
6.
go back to reference Giacobbe DR, Mikulska M, Tumbarello M, Furfaro E, Spadaro M, Losito AR, et al. Combined use of serum (1,3)-beta-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units. Crit Care. 2017;21:176.CrossRef Giacobbe DR, Mikulska M, Tumbarello M, Furfaro E, Spadaro M, Losito AR, et al. Combined use of serum (1,3)-beta-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units. Crit Care. 2017;21:176.CrossRef
7.
go back to reference Spec A, Shindo Y, Burnham C-AD, Wilson S, Ablordeppey EA, Beiter ER, et al. T cells from patients with Candida sepsis display a suppressive immunophenotype. Crit Care. 2016;20:15.CrossRef Spec A, Shindo Y, Burnham C-AD, Wilson S, Ablordeppey EA, Beiter ER, et al. T cells from patients with Candida sepsis display a suppressive immunophenotype. Crit Care. 2016;20:15.CrossRef
8.
go back to reference Cortegiani A, Russotto V, Raineri SM, Gregoretti C, Giarratano A. Dying with or because of invasive fungal infection? The role of immunity exhaustion on patient outcome. Turk J Anaesthesiol Reanim. 2016;44:285–6.CrossRef Cortegiani A, Russotto V, Raineri SM, Gregoretti C, Giarratano A. Dying with or because of invasive fungal infection? The role of immunity exhaustion on patient outcome. Turk J Anaesthesiol Reanim. 2016;44:285–6.CrossRef
9.
go back to reference Russotto V, Cortegiani A, Raineri SM, Giarratano A. From bedside to bench: the missing brick for patients with fungal sepsis. Crit Care. 2016;20:191.CrossRef Russotto V, Cortegiani A, Raineri SM, Giarratano A. From bedside to bench: the missing brick for patients with fungal sepsis. Crit Care. 2016;20:191.CrossRef
Metadata
Title
Biomarkers to delineate bacteremia from candidemia remain a challenging issue
Authors
Patrick M. Honore
Christina David
Rachid Attou
Sebastien Redant
Andrea Gallerani
David De Bels
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-019-2720-2

Other articles of this Issue 1/2020

Critical Care 1/2020 Go to the issue